About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ulcerative Colitis Clinical Trials | 460 Studies Recruiting

Clinical TrialsUlcerative Colitis

Ulcerative Colitis Clinical Trials

Browse 460 clinical trials for ulcerative colitis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 460 trials

CompletedPhenotyping IBS: Perceptions and Modulations of Visceral SensationsThe purpose of this research study is to improve the understanding of irritable bowel syndrome (IBS) and its underlying cause.NCT02693730·Los Angeles, California CompletedA Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseUlcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).Crohn's disease…NCT04254783·Coronado, California and 5 others

Related Searches

Data from ClinicalTrials.govTerms

Not yet recruitingAccuracy of Modified Milan Ultrasound Criteria in Assessing Disease Activity and Severity in Moderate-to-Severe Ulcerative Colitis: a Pilot StudyLongitudinal prospective monocentric observational study in which patients to start Mirikizumab for normal clinical practice will be followed for 24 weeks.NCT07358923

Enrolling by invitationEnabling Microbiomics- Driven Personalized NutritionThe goal of this observational research study is to determine how diet contributes to various gastrointestinal related conditions.NCT06657001·Rochester, Minnesota

CompletedAn Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative ColitisThis multi-centre open label study will involve a minimum of 120 patients in 2 cohorts: 60 patients with 'early UC' defined as disease duration \< 4 years and no other treatments…NCT02646657·Bonheiden and 19 others

TerminatedEvaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative ColitisThis is a randomized, double blind, placebo-controlled, parallel group multi-center study in adult participants with active moderate to severe UC.NCT01671956·Afula and 5 others

Active not recruitingProspective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)To describe the effectiveness, treatment patterns, quality of life, and safety of participants with moderately or severely active UC treated with filgotinib in a real-world…NCT05817942·Graz and 80 others

CompletedFeasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative ColitisThis is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active…NCT05743153·Nijmegen

CompletedReport of a New Method Used to Identify the Bacteria Present in a Human Colon Biopsy SampleThe method used for the biopsy analysis may be able to provide important insights into the complex microbial communities found in the human colon or in complex human infections.NCT00882752

CompletedA Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) InhibitorsThis Phase III, randomized, double-blind, parallel-grouped, placebo-controlled, multicenter study will investigate the efficacy and safety of etrolizumab in maintenance of…NCT02165215·Orange, California and 103 others

UnknownGolimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in ColitisGLM dose Optimisation to Adequate Levels to Achieve Response in Colitis (GOAL-ARC).NCT02687724·Dublin

TerminatedThe Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or ProctosigmoiditisThe purpose of this study is to evaluate safety and tolerability of cyclically-dosed rectal budesonide foam in participants with active ulcerative proctitis (UP) or ulcerative…NCT01349673·Houston, Texas

UnknownMultistrain Probiotics Reduces UC Depression and Anxiety ScoresThis pilot study aims to evaluate the effect of a 16-week duration of multistrain probiotic product (De Simone Fomulation (DSF), previously known as VSL#3 and now available as…NCT04006977·Xi'an, Shaanxi

RecruitingND-12 Combined With H-6 for Adult Chronic Inflammatory DiarrheaThis is a randomized controlled trial to explore the efficacy and safety of ND-12 combined with H-6 for patients with chronic inflammatory diarrheaNCT07767370·Nanjing, Jiangsu

Active not recruitingA Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))The protocol of this Phase 2 clinical trial consists of a double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of dupilumab in…NCT05731128·Apple Valley, California and 76 others

CompletedSub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging MarketsThe purpose of this study is to establish the incidence of sub-optimal response to anti-TNF therapy in UC and CD participants.NCT03090139·Ciudad Autonoma Buenos Aires, Buenos Aires and 75 others

RecruitingStudy of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative ColitisThe aim of the study is to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics and immunogenicity of study drug (BCD-261) in comparison with placebo and to…NCT07080034·Barnaul, Altayskiy Kray and 19 others

CompletedPredicting Response to Vedolizumab in Pediatric Inflammatory Bowel DiseasesVedolizumab (VDZ) is a humanized immunoglobulin G1 monoclonal antibody acting against α4β7 integrin which modulates lymphocyte trafficking in the gut.NCT02862132·Hartford, Connecticut and 14 others

Active not recruitingAn Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World PracticeUlcerative colitis (UC) is an idiopathic, chronic, inflammatory disease affecting the colon.NCT05494606·Ciudad Autonoma de Buenos Aire, Buenos Aires F.D. and 152 others

CompletedA Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)This study will evaluate the efficacy and safety of CBP-307 in subjects with moderate to severe ulcerative colitis (UC).NCT04700449·Phoenix, Arizona and 65 others

PreviousPage 4 of 23Next